Iovance Biotherapeutics, Inc. SEC filings IOVA

Iovance Biotherapeutics, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Oct 1, 2010. Its latest annual report, Form ARS, was filed on May 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders May 1, 2026 Dec 31, 2025
10-K Annual report Feb 24, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
10-K Annual report Feb 27, 2025 Dec 31, 2024
ARS Annual report to shareholders May 1, 2024 Dec 31, 2023
10-K Annual report Feb 28, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 27, 2023 Dec 31, 2022
10-K Annual report Feb 28, 2023 Dec 31, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
10-K Annual report Feb 25, 2020 Dec 31, 2019
10-K Annual report Feb 28, 2019 Dec 31, 2018
10-K Annual report Mar 12, 2018 Dec 31, 2017
10-K Annual report Mar 9, 2017 Dec 31, 2016
10-K Annual report Mar 11, 2016 Dec 31, 2015
10-K/A Amended annual report Apr 20, 2015 Dec 31, 2014
10-K Annual report Mar 16, 2015 Dec 31, 2014
10-K Annual report Mar 28, 2014 Dec 31, 2013
10-K Annual report Sep 23, 2013 Dec 31, 2012
10-K Annual report Mar 30, 2012 Dec 31, 2011
10-K/A Amended annual report May 4, 2011 Dec 31, 2010
10-K Annual report Apr 14, 2011 Dec 31, 2010

Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
IOVA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Carlos, CA
SEC filer status
Accelerated filer
SEC CIK
1425205
Former names
Lion Biotechnologies, Inc. (until Jun 5, 2017); Genesis Biopharma, Inc (until Sep 23, 2013); FREIGHT MANAGEMENT CORP (until Mar 8, 2010)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.